-
EP3348553
European procedure
Extract from the Register of European Patents
EP About this file: EP3348553
| EP3348553 - CRYSTALLINE FORMS OF AN ANDROGEN RECEPTOR MODULATOR [Right-click to bookmark this link] | Status | Patent revoked Status updated on 31.07.2024 Database last updated on 03.04.2025 | |
| Former | The patent has been granted Status updated on 05.06.2020 | ||
| Former | Grant of patent is intended Status updated on 22.01.2020 | ||
| Former | Request for examination was made Status updated on 18.01.2019 | ||
| Former | The application has been published Status updated on 15.06.2018 | Most recent event Tooltip | 02.08.2024 | Revocation of patent | published on 04.09.2024 [2024/36] | Applicant(s) | For all designated states Aragon Pharmaceuticals, Inc. 10990 Wilshire Blvd. Suite 300 Los Angeles, CA 90024 / US | For all designated states Sloan-Kettering Institute for Cancer Research 1275 York Avenue New York, NY 10065 / US | [2020/24] |
| Former [2018/29] | For all designated states Aragon Pharmaceuticals, Inc. 12780 El Camino Real, Suite 301 San Diego, CA 92130 / US | ||
| For all designated states Sloan-Kettering Institute for Cancer Research 1275 York Avenue New York, NY 10065 / US | Inventor(s) | 01 /
DILHAS, Anna Häsingerstr. 32 4055 Basel / CH | 02 /
OUERFELLI, Ouathek 2077 Center Avenue, Apt. 3J Fort Lee, NJ 07024 / US | 03 /
SMITH, Nicholas D. 1204 Beryl Street San Diego, CA 92109 / US | 04 /
HERBERT, Mark R. 4180 Amoroso Street San Diego, CA 92111 / US | [2018/29] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
| Former [2018/29] | McGuire, Gillian Margaret, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | Application number, filing date | 18157435.1 | 04.06.2013 | [2018/29] | Priority number, date | US201261656888P | 07.06.2012 Original published format: US 201261656888 P | [2018/29] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3348553 | Date: | 18.07.2018 | Language: | EN | [2018/29] | Type: | B1 Patent specification | No.: | EP3348553 | Date: | 08.07.2020 | Language: | EN | [2020/28] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 13.04.2018 | Classification | IPC: | C07D401/04, A61K31/4439, A61K31/4184, A61P35/00 | [2018/29] | CPC: |
C07D401/04 (EP,CN,EA,IL,KR,US);
A61K31/4184 (EA,IL,KR);
A61K31/4439 (EA,IL,KR);
A61P13/08 (EP,IL);
A61P15/00 (EP,IL);
A61P33/00 (EP,IL);
A61P35/00 (EP,EA,IL);
A61P5/00 (EP,IL);
A61P5/28 (EP,IL);
C07B2200/13 (CN,IL)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/08] |
| Former [2018/29] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | 03.01.2019 | ME | 03.01.2019 | Title | German: | KRISTALLINE FORMEN EINES ANDROGENREZEPTORMODULATORS | [2018/29] | English: | CRYSTALLINE FORMS OF AN ANDROGEN RECEPTOR MODULATOR | [2018/29] | French: | FORMES CRISTALLINES D'UN MODULATEUR DE RÉCEPTEUR D'ANDROGÈNE | [2018/29] | Examination procedure | 03.01.2019 | Amendment by applicant (claims and/or description) | 03.01.2019 | Examination requested [2019/08] | 03.01.2019 | Date on which the examining division has become responsible | 23.01.2020 | Communication of intention to grant the patent | 01.06.2020 | Fee for grant paid | 01.06.2020 | Fee for publishing/printing paid | 01.06.2020 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP13800681.2 / EP2858985 | Divisional application(s) | EP19169275.5 / EP3533792 | EP21171579.2 / EP3922629 | Opposition(s) | Opponent(s) | 01
08.04.2021
12.04.2021
ADMISSIBLE SANDOZ AG Lichtstrasse 35 4056 Basel / CH Opponent's representative Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE | 02
08.04.2021
12.04.2021
ADMISSIBLE Scorpio IP Limited Mercury House 19-21 Chapel Street Marlow Buckinghamshire SL7 3HN / GB Opponent's representative Sagittarius IP Marlow International Parkway Marlow SL7 1YL / GB | [N/P] |
| Former [2022/07] | |||
| Opponent(s) | 01
08.04.2021
12.04.2021
ADMISSIBLE SANDOZ AG Lichtstrasse 35 4056 Basel / CH Opponent's representative Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE | ||
| 02
08.04.2021
12.04.2021
ADMISSIBLE Scorpio IP Limited Mercury House 19-21 Chapel Street Marlow Buckinghamshire SL7 3HN / GB Opponent's representative Sagittarius IP Marlow International Parkway Marlow, SL7 1YL / GB | |||
| Former [2021/20] | |||
| Opponent(s) | 01
08.04.2021
12.04.2021
ADMISSIBLE SANDOZ AG Lichtstrasse 35 4056 Basel / CH Opponent's representative Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE | ||
| 02
08.04.2021
12.04.2021
ADMISSIBLE Sagittarius Intellectual Property Consultants Ltd Mercury House 19-21 Chapel Street Marlow Buckinghamshire SL7 3HN / GB Opponent's representative Sagittarius IP Marlow International Parkway Marlow, SL7 1YL / GB | |||
| Former [2021/19] | |||
| Opponent(s) | 01
08.04.2021
SANDOZ AG Lichtstrasse 35 4056 Basel / CH Opponent's representative Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE | deleted | Deletion: Legal effect of rejection of opposition [ N /P ] | 22.04.2021 | Invitation to proprietor to file observations on the notice of opposition | 01.09.2021 | Reply of patent proprietor to notice(s) of opposition | 14.09.2022 | Date of oral proceedings | 11.11.2022 | Despatch of minutes of oral proceedings | 11.11.2022 | Date of despatch of rejection of opposition | 16.05.2024 | Legal effect of revocation of patent [2024/36] | 31.07.2024 | Despatch of communication that the patent will be revoked | Appeal following opposition | 11.01.2023 | Appeal received No. T0039/23 | 11.01.2023 | Payment of appeal fee | 21.03.2023 | Statement of grounds filed | 16.05.2024 | Result of appeal procedure: revocation of the patent | 31.07.2024 | Despatch of the decision of the Board of Appeal | 06.01.2023 | Appeal received No. T0039/23 | 06.01.2023 | Payment of appeal fee | 21.03.2023 | Statement of grounds filed | 16.05.2024 | Result of appeal procedure: revocation of the patent | 31.07.2024 | Despatch of the decision of the Board of Appeal | 16.05.2024 | Date of oral proceedings | Fees paid | Renewal fee | 19.02.2018 | Renewal fee patent year 03 | 19.02.2018 | Renewal fee patent year 04 | 19.02.2018 | Renewal fee patent year 05 | 11.06.2018 | Renewal fee patent year 06 | 13.06.2019 | Renewal fee patent year 07 | 31.03.2020 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2022/23] |
| Former [2021/25] | AL | 08.07.2020 | Documents cited: | Search | [A]WO2007126765 (UNIV CALIFORNIA [US], et al); | [I]WO2008119015 (SLOAN KETTERING INST CANCER [US], et al); | [A]WO2011103202 (ARAGON PHARMACEUTICALS INC [US], et al); | by applicant | US5323907 | US20100450423 | Opposition | WO2008119015 | WO2013184681 | WO2007126765 | EP3812378 |